title: CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients.
authors.forename: S
authors.initials: S
authors.lastname: Minuzzo
authors.forename: S
authors.initials: S
authors.lastname: Indraccolo
authors.forename: V
authors.initials: V
authors.lastname: Tosello
authors.forename: E
authors.initials: E
authors.lastname: Piovan
authors.forename: A
authors.initials: A
authors.lastname: Cabrelle
authors.forename: L
authors.initials: L
authors.lastname: Trentin
authors.forename: G
authors.initials: G
authors.lastname: Semenzato
authors.forename: A
authors.initials: A
authors.lastname: Amadori
mesh_terms: D015703:Antigens, CD / Q000378:metabolism*; D014408:Biomarkers, Tumor; D019013:CD40 Antigens / Q000378:metabolism*; D051925:CD79 Antigens; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D016130:Immunophenotyping; D015448:Leukemia, B-Cell / Q000378:metabolism* / Q000503:physiopathology; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D051562:Proto-Oncogene Proteins c-bcr
chemical_list: D015703:Antigens, CD; D014408:Biomarkers, Tumor; D019013:CD40 Antigens; D051925:CD79 Antigens; C497883:CD79B protein, human; D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C496613:BCR protein, human; D051562:Proto-Oncogene Proteins c-bcr